ID
38162
Beskrivning
Study ID: 105-123 Clinical Study ID: 105-123 Study Title: Lamotrigine as add-on therapy in patients with clinical diagnosis of a Lennox-Gastaut syndrome (severe generalised epilepsy of childhood onset.) A multicentre, double-blind, placebo controlled parallel group study Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Lamotrigine Study Indication: Seizures
Nyckelord
Versioner (1)
- 23-09-19 23-09-19 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
23 september 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Lamotrigine as add-on therapy in patients with a clinical diagnosis of a Lennox-Gastaut syndrome (105-123)
Comment Log; Investigator's Statement
- StudyEvent: ODM
Beskrivning
Comment Log
Alias
- UMLS CUI-1
- C0947611
Beskrivning
Investigator's Statement
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C1710187
Beskrivning
I confirm that I have carefully examined all entries on the Case Report Forms for this patient. All Information entered by myself or my colleagues is, to the best of my knowledge, correct as of the date below.
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1519316
- UMLS CUI [1,2]
- C1521895
Beskrivning
Principal Investigator's Name
Datatyp
text
Alias
- UMLS CUI [1]
- C2826892
Beskrivning
Signature Date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Comment Log; Investigator's Statement
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1710187 (UMLS CUI-2)
C1521895 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Inga kommentarer